Valérie Boudreau

564 total citations
40 papers, 386 citations indexed

About

Valérie Boudreau is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Valérie Boudreau has authored 40 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 13 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Surgery. Recurrent topics in Valérie Boudreau's work include Cystic Fibrosis Research Advances (30 papers), Diabetes Management and Research (10 papers) and Diabetes Treatment and Management (9 papers). Valérie Boudreau is often cited by papers focused on Cystic Fibrosis Research Advances (30 papers), Diabetes Management and Research (10 papers) and Diabetes Treatment and Management (9 papers). Valérie Boudreau collaborates with scholars based in Canada, France and United States. Valérie Boudreau's co-authors include Rémi Rabasa‐Lhoret, Katherine Desjardins, Adèle Coriati, François Tremblay, Annick Lavoie, Kathryn J. Potter, Peter Senior, Quitterie Reynaud, Yves Berthiaume and I. Durieu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Valérie Boudreau

34 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valérie Boudreau Canada 12 316 97 72 63 58 40 386
Marcia Katz United States 5 446 1.4× 140 1.4× 95 1.3× 58 0.9× 58 1.0× 8 564
Marina Litvin United States 10 213 0.7× 73 0.8× 59 0.8× 62 1.0× 28 0.5× 12 353
José Loureiro-Amigo Portugal 10 49 0.2× 44 0.5× 14 0.2× 34 0.5× 26 0.4× 37 260
Helen M. Buntain Australia 10 213 0.7× 23 0.2× 8 0.1× 33 0.5× 20 0.3× 14 337
N. Sharief United Kingdom 9 163 0.5× 66 0.7× 68 0.9× 13 0.2× 4 0.1× 24 316
Richard R. Dooley United States 10 245 0.8× 86 0.9× 11 0.2× 44 0.7× 11 0.2× 14 341
Fabio Panetta Italy 12 58 0.2× 194 2.0× 6 0.1× 59 0.9× 25 0.4× 25 474
Laura San Feliciano Spain 14 195 0.6× 77 0.8× 15 0.2× 11 0.2× 4 0.1× 28 326
Jonathan McCormick United Kingdom 11 552 1.7× 50 0.5× 3 0.0× 26 0.4× 30 0.5× 13 628
D. Caldari France 9 49 0.2× 112 1.2× 5 0.1× 66 1.0× 14 0.2× 31 279

Countries citing papers authored by Valérie Boudreau

Since Specialization
Citations

This map shows the geographic impact of Valérie Boudreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valérie Boudreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valérie Boudreau more than expected).

Fields of papers citing papers by Valérie Boudreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valérie Boudreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valérie Boudreau. The network helps show where Valérie Boudreau may publish in the future.

Co-authorship network of co-authors of Valérie Boudreau

This figure shows the co-authorship network connecting the top 25 collaborators of Valérie Boudreau. A scholar is included among the top collaborators of Valérie Boudreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valérie Boudreau. Valérie Boudreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yardley, John P., Virginie Messier, Valérie Boudreau, et al.. (2025). Exploring perceived barriers to physical activity among individuals with type 1 diabetes in the era of new technologies: An analysis from the BETTER registry. Diabetes & Metabolism. 51(5). 101677–101677.
2.
3.
Messier, Virginie, Valérie Boudreau, Virginie Calderon, et al.. (2024). Overweight and Obesity in People Living With Type 1 Diabetes: A Cross‐Sectional Analysis of the BETTER Registry. Diabetes/Metabolism Research and Reviews. 40(6). e3837–e3837. 7 indexed citations
4.
Cheng, Ran, Nadine Taleb, Valérie Boudreau, et al.. (2024). Managing Impending Nonsevere Hypoglycemia With Oral Carbohydrates in Type 1 Diabetes: The REVERSIBLE Trial. Diabetes Care. 47(3). 476–482. 5 indexed citations
5.
Coriati, Adèle, et al.. (2024). Cystic Fibrosis–related Diabetes: A First Canadian Clinical Practice Guideline. Canadian Journal of Diabetes. 49(1). 19–28.e16. 5 indexed citations
6.
Boudreau, Valérie, et al.. (2024). Feasibility and accuracy of at-home glucose tolerance tests for cystic fibrosis related diabetes screening. Journal of Cystic Fibrosis. 23(5). 857–862.
7.
Potter, Kathryn J., Adèle Coriati, Larry C. Lands, et al.. (2023). Canadian Cystic Fibrosis–related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care. Canadian Journal of Diabetes. 47(3). 263–271.e1. 5 indexed citations
8.
Potter, Kathryn J., Valérie Boudreau, Julie Lacombe, et al.. (2023). Low vitamin K status in adults with cystic fibrosis is associated with reduced body mass index, insulin secretion, and increased pseudomonal colonization. Applied Physiology Nutrition and Metabolism. 48(4). 321–330. 3 indexed citations
9.
Potter, Kathryn J., Valérie Boudreau, François Tremblay, et al.. (2022). Insulinogenic index and early phase insulin secretion predict increased risk of worsening glucose tolerance and of cystic fibrosis-related diabetes. Journal of Cystic Fibrosis. 22(1). 50–58. 11 indexed citations
10.
Potter, Kathryn J., Valérie Boudreau, François Tremblay, et al.. (2022). Marginal association of fasting blood glucose with the risk of cystic fibrosis-related diabetes. Annales d Endocrinologie. 84(2). 265–271. 3 indexed citations
11.
Boudreau, Valérie, Quitterie Reynaud, Angélique Denis, et al.. (2021). Impact of 1h oral glucose tolerance test on the clinical status of adult cystic fibrosis patients over a 4-year period. PLoS ONE. 16(3). e0246897–e0246897. 11 indexed citations
12.
Potter, Kathryn J., Quitterie Reynaud, Valérie Boudreau, et al.. (2021). Prevalence of Post–Glucose Challenge Hypoglycemia in Adult Patients With Cystic Fibrosis and Relevance to the Risk of Cystic Fibrosis–Related Diabetes. Canadian Journal of Diabetes. 46(3). 294–301.e2. 1 indexed citations
13.
Potter, Kathryn J., Valérie Boudreau, Katherine Desjardins, et al.. (2021). Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis. Diabetologia. 64(6). 1332–1341. 18 indexed citations
14.
Shohoudi, Azadeh, Valérie Boudreau, Katherine Desjardins, et al.. (2021). Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study. Canadian Journal of Diabetes. 45(8). 768–774. 14 indexed citations
15.
Potter, Kathryn J., Valérie Boudreau, François Tremblay, et al.. (2021). Insulinogenic Index and Early Phase Insulin Secretion Predict Increased Risk of Worsening Glucose Tolerance and of Cystic Fibrosis-Related Diabetes. Canadian Journal of Diabetes. 45(7). S33–S33. 1 indexed citations
16.
17.
Rabasa‐Lhoret, Rémi, et al.. (2020). Dyslipidemia is not associated with the development of glucose intolerance or diabetes in cystic fibrosis. Journal of Cystic Fibrosis. 19(5). 704–711. 9 indexed citations
18.
19.
Boudreau, Valérie, et al.. (2018). Extra-skeletal impact of vitamin D supplementation protocol in an adult population with cystic fibrosis. Clinical Nutrition. 38(4). 1666–1671. 7 indexed citations
20.
Boudreau, Valérie, François Tremblay, Annick Lavoie, et al.. (2017). Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia. Journal of Cystic Fibrosis. 16(3). 418–424. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcia Katz Breakdown of academic impact, for papers by Marina Litvin Breakdown of academic impact, for papers by José Loureiro-Amigo Breakdown of academic impact, for papers by Helen M. Buntain Breakdown of academic impact, for papers by N. Sharief Breakdown of academic impact, for papers by Richard R. Dooley Breakdown of academic impact, for papers by Fabio Panetta Breakdown of academic impact, for papers by Laura San Feliciano Breakdown of academic impact, for papers by Jonathan McCormick Breakdown of academic impact, for papers by D. Caldari
Rankless by CCL
2026